Benzinga | Oct 30, 2020 08:03AM EDT

Ligand Pharmaceuticals Q3 Adj. EPS $1.04 Beats $0.98 Estimate, Sales $41.80M Miss $44.36M Estimate

Ligand Pharmaceuticals (NASDAQ:LGND) reported quarterly earnings of $1.04 per share which beat the analyst consensus estimate of $0.98 by 6.12 percent. This is a 112.24 percent increase over earnings of $0.49 per share from the same period last year. The company reported quarterly sales of $41.80 million which missed the analyst consensus estimate of $44.36 million by 5.77 percent. This is a 68.49 percent increase over sales of $24.81 million the same period last year.